Trellus Health plc (TRLS.L)
- Previous Close
1.8500 - Open
2.0000 - Bid 1.7000 x --
- Ask --
- Day's Range
1.8000 - 2.0000 - 52 Week Range
0.5000 - 5.4000 - Volume
740,100 - Avg. Volume
879,098 - Market Cap (intraday)
2.988M - Beta (5Y Monthly) 2.30
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date May 26, 2025 - Jun 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a proprietary HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
www.trellushealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TRLS.L
View MorePerformance Overview: TRLS.L
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRLS.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRLS.L
View MoreValuation Measures
Market Cap
2.99M
Enterprise Value
-3.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
72.89
Price/Book (mrq)
0.26
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-22.76%
Return on Equity (ttm)
-35.08%
Revenue (ttm)
55k
Net Income Avi to Common (ttm)
-6.66M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
8.04M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.44M